Tennessee House Bill HB0202

Tennessee 2023-2024 Regular Session

• Introduced: 1/13/23
• Refer: 1/21/23
• Refer: 2/6/23
• Engrossed: 2/14/23
• Enrolled: 2/24/23
• Passed: 3/10/23
• Chaptered: 3/23/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 4, Chapter 29 and Title 53, relative to the controlled substance database committee.

Impact

The amendments proposed in HB 202 will have significant implications for state laws surrounding the regulation of controlled substances. By streamlining the functions of the controlled substance database committee, the bill aims to improve the effectiveness of drug monitoring and regulation. This, in turn, could lead to better tracking of prescription medications, which is critical in combating substance abuse and ensuring that proper measures are in place to protect public health. The legislative intent behind this bill is to bolster Tennessee's framework for addressing substance-related issues, thereby providing a more robust legal basis for managing these challenges.

Summary

House Bill 202 seeks to amend existing provisions in the Tennessee Code Annotated related to the controlled substance database committee. The primary focus of the bill is to update the committee's organizational structure and functions, potentially enhancing the state's ability to monitor and regulate controlled substances. The revisions aim to address any deficiencies in the current law and strengthen the state's efforts in managing issues surrounding substance control, which has become increasingly important in light of public health concerns related to drug abuse and addiction.

Sentiment

Overall, the sentiment surrounding HB 202 appears to be positive. Lawmakers from both sides of the aisle seem to recognize the importance of addressing substance abuse issues proactively, indicating a collaborative spirit in tackling public health challenges. The unanimous support in the initial voting phase suggests that there is a collective agreement on the necessity of updating the regulatory framework governing controlled substances, positioning the bill as a vital step forward in addressing these vital issues.

Contention

While there does not appear to be significant opposition to HB 202, some concerns regarding the implementation of changes and potential costs may arise in discussions among stakeholders. Critics could argue that without proper resources or training, simply revising the committee's structure might not yield the desired results. However, these counterarguments have not manifested strongly in current discussions, indicating a predominately favorable consensus on the necessity of the bill.